title: Alternative strategy for overcoming ABO incompatibility.
authors.forename: Takaaki
authors.initials: T
authors.lastname: Kobayashi
authors.forename: Dage
authors.initials: D
authors.lastname: Liu
authors.forename: Haruko
authors.initials: H
authors.lastname: Ogawa
authors.forename: Yuko
authors.initials: Y
authors.lastname: Miwa
authors.forename: Takaharu
authors.initials: T
authors.lastname: Nagasaka
authors.forename: Shoichi
authors.initials: S
authors.lastname: Maruyama
authors.forename: Yu-Teh
authors.initials: YT
authors.lastname: Li
authors.forename: Akira
authors.initials: A
authors.lastname: Onishi
authors.forename: Takafumi
authors.initials: T
authors.lastname: Kuzuya
authors.forename: Kenji
authors.initials: K
authors.lastname: Kadomatsu
authors.forename: Kazuharu
authors.initials: K
authors.lastname: Uchida
authors.forename: Akimasa
authors.initials: A
authors.lastname: Nakao
mesh_terms: D000017:ABO Blood-Group System / Q000276:immunology; D000818:Animals; D001789:Blood Group Antigens / Q000276:immunology / Q000302:isolation & purification; D001787:Blood Group Incompatibility / Q000517:prevention & control*; D003167:Complement Activation / Q000187:drug effects; D006026:Glycoside Hydrolases / Q000494:pharmacology*; D006801:Humans; D007518:Isoantibodies / Q000187:drug effects / Q000276:immunology; D010215:Papio; D011994:Recombinant Proteins / Q000494:pharmacology
chemical_list: D000017:ABO Blood-Group System; D001789:Blood Group Antigens; D007518:Isoantibodies; D011994:Recombinant Proteins; D006026:Glycoside Hydrolases; C026093:keratan-sulfate endo-1,4-beta-galactosidase